APOA1 and Alzheimer disease: Recent studies have reported a significant reduction in circulating ApoA-I levels in AD patients compared to cognitively healthy individuals, suggesting that ApoA-I deficiency, rather than HDL quantity alone, may contribute to increased AD risk [80].